260 related articles for article (PubMed ID: 16956591)
1. Ebselen effects on MPTP-induced neurotoxicity.
Dhanasekaran M; Uthayathas S; Karuppagounder SS; Parameshwaran K; Suppiramaniam V; Ebadi M; Brown-Borg HM
Brain Res; 2006 Nov; 1118(1):251-4. PubMed ID: 16956591
[TBL] [Abstract][Full Text] [Related]
2. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Muralikrishnan D; Samantaray S; Mohanakumar KP
Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
[TBL] [Abstract][Full Text] [Related]
3. The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson's disease.
Moussaoui S; Obinu MC; Daniel N; Reibaud M; Blanchard V; Imperato A
Exp Neurol; 2000 Dec; 166(2):235-45. PubMed ID: 11085889
[TBL] [Abstract][Full Text] [Related]
4. Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain.
Oida Y; Kitaichi K; Nakayama H; Ito Y; Fujimoto Y; Shimazawa M; Nagai H; Hara H
Brain Res; 2006 Apr; 1082(1):196-204. PubMed ID: 16515773
[TBL] [Abstract][Full Text] [Related]
5. Effects of cysteamine on MPTP-induced dopaminergic neurodegeneration in mice.
Sun L; Xu S; Zhou M; Wang C; Wu Y; Chan P
Brain Res; 2010 Jun; 1335():74-82. PubMed ID: 20380823
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evidences that antioxidant action contributes to the neuroprotective effects of the neuronal nitric oxide synthase and monoamine oxidase-B inhibitor, 7-nitroindazole.
Thomas B; Saravanan KS; Mohanakumar KP
Neurochem Int; 2008 May; 52(6):990-1001. PubMed ID: 18164516
[TBL] [Abstract][Full Text] [Related]
7. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.
Haobam R; Sindhu KM; Chandra G; Mohanakumar KP
Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective aspects of a novel MAO-B inhibitor PF9601N.
Pérez V; Morón J; Pastó M; Unzeta M
Neurobiology (Bp); 2000; 8(3-4):231-6. PubMed ID: 11225513
[TBL] [Abstract][Full Text] [Related]
9. Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice.
Ohashi S; Mori A; Kurihara N; Mitsumoto Y; Nakai M
Neurosci Lett; 2006 Jun; 401(1-2):183-7. PubMed ID: 16581184
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective rather than neurorescue or neurorestorative effect of selegiline against MPTP-induced dopaminergic toxicity.
Wu WR; Zhu XZ; Guan HJ; Wang RG; Ji XQ
Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):146-50. PubMed ID: 10437162
[TBL] [Abstract][Full Text] [Related]
11. A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.
Kawasaki T; Ago Y; Kitao T; Nashida T; Takagi A; Takuma K; Matsuda T
Neuropharmacology; 2008 Oct; 55(5):654-60. PubMed ID: 18573265
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotection in Parkinson models varies with toxin administration protocol.
Anderson DW; Bradbury KA; Schneider JS
Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
[TBL] [Abstract][Full Text] [Related]
13. Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X
Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563
[TBL] [Abstract][Full Text] [Related]
14. Minocycline enhances MPTP toxicity to dopaminergic neurons.
Yang L; Sugama S; Chirichigno JW; Gregorio J; Lorenzl S; Shin DH; Browne SE; Shimizu Y; Joh TH; Beal MF; Albers DS
J Neurosci Res; 2003 Oct; 74(2):278-85. PubMed ID: 14515357
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of ebselen are associated with the regulation of Bcl-2 and Bax proteins in cultured mouse cortical neurons.
Xu JH; Hu HT; Liu Y; Qian YH; Liu ZH; Tan QR; Zhang ZJ
Neurosci Lett; 2006 May; 399(3):210-4. PubMed ID: 16513270
[TBL] [Abstract][Full Text] [Related]
16. Ebselen augments its peroxidase activity by inducing nrf-2-dependent transcription.
Tamasi V; Jeffries JM; Arteel GE; Falkner KC
Arch Biochem Biophys; 2004 Nov; 431(2):161-8. PubMed ID: 15488464
[TBL] [Abstract][Full Text] [Related]
17. Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
Anderson DW; Bradbury KA; Schneider JS
Eur J Neurosci; 2008 Aug; 28(3):610-7. PubMed ID: 18702732
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of SUN N8075, a novel agent with antioxidant properties, in in vitro and in vivo models of Parkinson's disease.
Oyagi A; Oida Y; Hara H; Izuta H; Shimazawa M; Matsunaga N; Adachi T; Hara H
Brain Res; 2008 Jun; 1214():169-76. PubMed ID: 18457816
[TBL] [Abstract][Full Text] [Related]
19. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells.
Kim SJ; Park C; Han AL; Youn MJ; Lee JH; Kim Y; Kim ES; Kim HJ; Kim JK; Lee HK; Chung SY; So H; Park R
Hear Res; 2009 May; 251(1-2):70-82. PubMed ID: 19286452
[TBL] [Abstract][Full Text] [Related]
20. Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism.
Muñoz A; Rey P; Guerra MJ; Mendez-Alvarez E; Soto-Otero R; Labandeira-Garcia JL
Neuropharmacology; 2006 Jul; 51(1):112-20. PubMed ID: 16678218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]